JP2019201661A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019201661A5 JP2019201661A5 JP2019141485A JP2019141485A JP2019201661A5 JP 2019201661 A5 JP2019201661 A5 JP 2019201661A5 JP 2019141485 A JP2019141485 A JP 2019141485A JP 2019141485 A JP2019141485 A JP 2019141485A JP 2019201661 A5 JP2019201661 A5 JP 2019201661A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- culture medium
- cells
- adamts13
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021079239A JP7083059B2 (ja) | 2009-07-31 | 2021-05-07 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23047709P | 2009-07-31 | 2009-07-31 | |
| US61/230,477 | 2009-07-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018011373A Division JP6567707B2 (ja) | 2009-07-31 | 2018-01-26 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021079239A Division JP7083059B2 (ja) | 2009-07-31 | 2021-05-07 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019201661A JP2019201661A (ja) | 2019-11-28 |
| JP2019201661A5 true JP2019201661A5 (https=) | 2020-01-23 |
| JP6883071B2 JP6883071B2 (ja) | 2021-06-09 |
Family
ID=42668009
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012523110A Active JP5451884B2 (ja) | 2009-07-31 | 2010-07-30 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
| JP2016093240A Active JP6511007B2 (ja) | 2009-07-31 | 2016-05-06 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
| JP2018011373A Active JP6567707B2 (ja) | 2009-07-31 | 2018-01-26 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
| JP2019141485A Active JP6883071B2 (ja) | 2009-07-31 | 2019-07-31 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
| JP2021079239A Active JP7083059B2 (ja) | 2009-07-31 | 2021-05-07 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012523110A Active JP5451884B2 (ja) | 2009-07-31 | 2010-07-30 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
| JP2016093240A Active JP6511007B2 (ja) | 2009-07-31 | 2016-05-06 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
| JP2018011373A Active JP6567707B2 (ja) | 2009-07-31 | 2018-01-26 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021079239A Active JP7083059B2 (ja) | 2009-07-31 | 2021-05-07 | Ａｄａｍｔｓタンパク質発現のための細胞培養培地 |
Country Status (21)
| Country | Link |
|---|---|
| US (7) | US8313926B2 (https=) |
| EP (1) | EP2459702B1 (https=) |
| JP (5) | JP5451884B2 (https=) |
| KR (5) | KR101808496B1 (https=) |
| CN (2) | CN104962539B (https=) |
| AU (1) | AU2010278751B2 (https=) |
| BR (2) | BR122021005965B1 (https=) |
| CA (1) | CA2769361A1 (https=) |
| CO (1) | CO6501191A2 (https=) |
| EA (1) | EA023193B1 (https=) |
| ES (1) | ES2583258T3 (https=) |
| HR (1) | HRP20160783T1 (https=) |
| HU (1) | HUE029110T2 (https=) |
| IN (1) | IN2012DN00801A (https=) |
| MX (2) | MX2012001261A (https=) |
| NZ (1) | NZ597727A (https=) |
| PL (1) | PL2459702T3 (https=) |
| PT (1) | PT2459702T (https=) |
| SG (1) | SG178194A1 (https=) |
| SI (1) | SI2459702T1 (https=) |
| WO (1) | WO2011014838A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104962539B (zh) * | 2009-07-31 | 2019-09-17 | 百深公司 | 用于adamts蛋白表达的细胞培养基 |
| CA2805557A1 (en) | 2010-07-08 | 2012-01-12 | Baxter International Inc. | Method of producing recombinant high molecular weight vwf in cell culture |
| DK2726600T3 (en) | 2011-07-01 | 2017-05-15 | Amgen Inc | Mammalian Cell Culture |
| EP2906683B1 (en) | 2012-10-15 | 2017-05-31 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
| WO2014159831A1 (en) | 2013-03-13 | 2014-10-02 | Merck Sharp & Dohme Corp. | Adapted lepidopteran insect cells for the production of recombinant proteins |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| KR20160068000A (ko) * | 2013-10-14 | 2016-06-14 | 아레스 트레이딩 에스.아. | 포유동물의 고성능 유가식 배양을 위한 신규 배지 |
| PT3152317T (pt) | 2014-06-04 | 2019-04-18 | Amgen Inc | Métodos de colheita de culturas de células de mamíferos |
| KR101867134B1 (ko) * | 2015-03-23 | 2018-06-12 | 한양대학교 산학협력단 | 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법 |
| ES2929531T3 (es) * | 2015-05-22 | 2022-11-30 | Dupont Nutrition Biosci Aps | Acetolactato descarboxilasa |
| TW202440904A (zh) | 2015-08-04 | 2024-10-16 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法（二） |
| US11191818B2 (en) | 2016-08-04 | 2021-12-07 | Takeda Pharmaceutical Company Limited | Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome |
| KR102482744B1 (ko) * | 2016-11-04 | 2022-12-30 | 다케다 야쿠힌 고교 가부시키가이샤 | 아데노-연관 바이러스 정제 방법 |
| KR102659791B1 (ko) * | 2017-07-06 | 2024-04-23 | 리제너론 파마슈티칼스 인코포레이티드 | 당단백질을 만들기 위한 세포 배양 과정 |
| IL277352B2 (en) * | 2018-03-16 | 2025-08-01 | Genzyme Corp | Methods for improving cell viability in a production bioreactor |
| CA3103443A1 (en) * | 2018-06-18 | 2019-12-26 | Synthetic Biologics, Inc. | Methods of making alkaline phosphatase agents |
| WO2021067668A1 (en) | 2019-10-04 | 2021-04-08 | The Children's Medical Center Corporation | Adamts13 treatment to enhance graft survival |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| US11180540B2 (en) | 2019-12-06 | 2021-11-23 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| WO2021198781A2 (en) | 2020-04-02 | 2021-10-07 | Takeda Pharmaceutical Company Limited | Adamts13 variant, compositions, and uses thereof |
| JP2023525034A (ja) | 2020-05-08 | 2023-06-14 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｖｅｇｆトラップおよびミニトラップならびに眼障害およびがんの治療方法 |
| JP2023526546A (ja) | 2020-05-22 | 2023-06-21 | 武田薬品工業株式会社 | コロナウイルス疾患の合併症の治療及び診断のための、ａｄａｍｔｓ１３組成物及び方法 |
| WO2021246557A1 (ko) * | 2020-06-05 | 2021-12-09 | 주식회사 프로앱텍 | 특정한 갯수의 알부민이 연결된 요산산화효소-알부민 복합체 및 이의 제조 방법 |
| CN111808822B (zh) * | 2020-07-02 | 2024-01-12 | 北京百普赛斯生物科技股份有限公司 | 细胞培养用补料液及提高重组hek293细胞蛋白表达量的方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5250421A (en) | 1986-01-03 | 1993-10-05 | Genetics Institute, Inc. | Method for producing factor VIII:C-type proteins |
| JPH0753104B2 (ja) * | 1989-02-28 | 1995-06-07 | 秀明 山田 | 細菌の培養法 |
| CZ280901B6 (cs) | 1988-10-06 | 1996-05-15 | Hideaki Yamada | Způsob kultivace bakterií |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| ES2378409T3 (es) | 1994-11-10 | 2012-04-12 | Baxter Healthcare S.A. | Método para producir sustancias biológicas en cultivo sin proteínas |
| DE69608668T2 (de) | 1995-02-23 | 2001-02-01 | Quest International B.V., Naarden | Peptide für gewebe- und zellkulturmedien |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| EP1482031B1 (en) | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| IT1285158B1 (it) * | 1996-09-17 | 1998-06-03 | Angeletti P Ist Richerche Bio | Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il |
| CN1102921C (zh) | 1996-10-07 | 2003-03-12 | 索罗蒂亚公司 | 苯羟基化的方法 |
| JP4543402B2 (ja) | 1996-10-10 | 2010-09-15 | ライフ テクノロジーズ コーポレーション | 植物由来栄養素を含む動物細胞培養培地 |
| US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
| US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
| AT407255B (de) | 1997-06-20 | 2001-02-26 | Immuno Ag | Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| US6406909B1 (en) | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US6926894B2 (en) * | 2000-11-22 | 2005-08-09 | Baxter Aktiengesellschaft | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| AU2003295270A1 (en) | 2002-12-23 | 2004-07-14 | Fuji Photo Film B.V. | Process for coating cell-culture support |
| CA2562683A1 (en) * | 2004-04-16 | 2005-12-08 | Wyeth | Adamts-8 proteins and uses thereof |
| US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| JP2007174948A (ja) * | 2005-12-27 | 2007-07-12 | Noritsu Koki Co Ltd | 酵素水製造装置 |
| JP4880997B2 (ja) * | 2005-12-28 | 2012-02-22 | アルフレッサファーマ株式会社 | Ａｄａｍｔｓ１３の安定化方法 |
| EP3653699A1 (en) * | 2006-01-04 | 2020-05-20 | Baxalta Incorporated | Oligopeptide-free cell culture media |
| BRPI0622214A2 (pt) * | 2006-12-22 | 2012-01-03 | Springer Carrier Ltda | unidade de condicionamento de ar e mÉtodo de misturar ar em uma unidade de condicionamento de ar |
| US20090067805A1 (en) | 2007-09-10 | 2009-03-12 | Victor Company Of Japan, Limited | Recording and reproducing device |
| PL2235197T3 (pl) * | 2007-12-27 | 2018-01-31 | Baxalta GmbH | Sposoby hodowli komórek |
| CN104962539B (zh) * | 2009-07-31 | 2019-09-17 | 百深公司 | 用于adamts蛋白表达的细胞培养基 |
-
2010
- 2010-07-30 CN CN201510186244.8A patent/CN104962539B/zh active Active
- 2010-07-30 EA EA201270224A patent/EA023193B1/ru not_active IP Right Cessation
- 2010-07-30 HR HRP20160783TT patent/HRP20160783T1/hr unknown
- 2010-07-30 SG SG2012006839A patent/SG178194A1/en unknown
- 2010-07-30 KR KR1020177018298A patent/KR101808496B1/ko active Active
- 2010-07-30 PL PL10740810.6T patent/PL2459702T3/pl unknown
- 2010-07-30 JP JP2012523110A patent/JP5451884B2/ja active Active
- 2010-07-30 KR KR1020157009715A patent/KR101574056B1/ko active Active
- 2010-07-30 PT PT107408106T patent/PT2459702T/pt unknown
- 2010-07-30 KR KR1020177035177A patent/KR101912552B1/ko active Active
- 2010-07-30 ES ES10740810.6T patent/ES2583258T3/es active Active
- 2010-07-30 NZ NZ597727A patent/NZ597727A/xx unknown
- 2010-07-30 BR BR122021005965-9A patent/BR122021005965B1/pt active IP Right Grant
- 2010-07-30 CA CA2769361A patent/CA2769361A1/en not_active Abandoned
- 2010-07-30 WO PCT/US2010/044020 patent/WO2011014838A1/en not_active Ceased
- 2010-07-30 BR BR112012002151-6A patent/BR112012002151B1/pt active IP Right Grant
- 2010-07-30 SI SI201031238A patent/SI2459702T1/sl unknown
- 2010-07-30 MX MX2012001261A patent/MX2012001261A/es active IP Right Grant
- 2010-07-30 US US12/847,999 patent/US8313926B2/en active Active
- 2010-07-30 KR KR1020127005425A patent/KR101573972B1/ko active Active
- 2010-07-30 AU AU2010278751A patent/AU2010278751B2/en active Active
- 2010-07-30 CN CN201080042028.1A patent/CN102549145B/zh active Active
- 2010-07-30 HU HUE10740810A patent/HUE029110T2/en unknown
- 2010-07-30 KR KR1020157033595A patent/KR101756354B1/ko active Active
- 2010-07-30 IN IN801DEN2012 patent/IN2012DN00801A/en unknown
- 2010-07-30 EP EP10740810.6A patent/EP2459702B1/en active Active
-
2012
- 2012-01-27 MX MX2013009470A patent/MX344970B/es unknown
- 2012-02-27 CO CO12033821A patent/CO6501191A2/es unknown
- 2012-09-19 US US13/622,939 patent/US8759026B2/en active Active
-
2014
- 2014-05-13 US US14/276,819 patent/US9127265B2/en active Active
-
2015
- 2015-07-23 US US14/807,745 patent/US9441216B2/en active Active
-
2016
- 2016-05-06 JP JP2016093240A patent/JP6511007B2/ja active Active
- 2016-08-09 US US15/232,626 patent/US10072254B2/en active Active
-
2018
- 2018-01-26 JP JP2018011373A patent/JP6567707B2/ja active Active
- 2018-09-08 US US16/125,688 patent/US10724024B2/en active Active
-
2019
- 2019-07-31 JP JP2019141485A patent/JP6883071B2/ja active Active
-
2020
- 2020-06-16 US US16/903,185 patent/US11254921B2/en active Active
-
2021
- 2021-05-07 JP JP2021079239A patent/JP7083059B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019201661A5 (https=) | ||
| JP2013500724A5 (https=) | ||
| HRP20160783T1 (hr) | Medij za kultiviranje stanica za ekspresiju adamts proteina | |
| US11136373B2 (en) | Fermentation process for increasing production level of recombinant human collagen | |
| Parks et al. | Enhanced measles virus cDNA rescue and gene expression after heat shock | |
| DE69720026T2 (de) | Verfahren zur herstellung von d-aminosäuren durch direkte gärung | |
| DE60315925D1 (de) | Verfahren zur Herstellung einer Zielsubstanz durch Fermentation mittels eines bakteriellen Stamms, dem das ArcA-Gen fehlt | |
| IE68408B1 (en) | Purification of hepatitis proteins | |
| WO2005080556A3 (en) | Virus purification methods | |
| JP7459362B1 (ja) | 組換えヒト型化コラーゲンおよびその応用 | |
| BR0012712B1 (pt) | métodos de produção de l-aminoácidos aumentando-se o nadph celular. | |
| DE60120619D1 (de) | Verfahren zur Herstellung einer Zielsubstanz durch Fermentation | |
| JP2009528843A5 (https=) | ||
| DE69931394D1 (de) | Verfahren zur herstellung von ascorbinsäure-zwischenprodukten | |
| CN102876630A (zh) | 一种高效分离和扩增人脐带血间充质干细胞的方法 | |
| CN109536494A (zh) | 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒 | |
| JPWO2020179380A5 (https=) | ||
| CN111218477A (zh) | 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用 | |
| JP2014518508A5 (https=) | ||
| CN106916775A (zh) | 高产纳米多聚磷酸体的转基因藻株及其制备方法 | |
| JP2005511087A5 (https=) | ||
| CN115651078A (zh) | 重组纤连-胶原蛋白高纯度高效率制备方法 | |
| US20230414665A1 (en) | Method for producing modified mesenchymal stromal stem cells with improved properties, modified cells obtained by this method, composition including such cells | |
| CN105601726B (zh) | Oct4在调控IL-31基因表达中的应用 | |
| CN105087510A (zh) | 一种重组Cu/Zn-SOD的发酵制备方法 |